News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2023-10-02 6:31:18 pm NewAmsterdam Pharma's Pioneering Pulse On Alzheimer's Breakthroughs SeekingAlpha
2023-09-21 4:0:0 am NewAmsterdam Pharma Announces Initial Data from Phase 2a Clinical Trial Evaluating Obicetrapib in Patients with Early Alzheimer’s Disease Who Carry an ApoE4 Mutation GlobeNewswire
2023-09-20 5:0:0 am NewAmsterdam Pharma to Present at 2023 Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
2023-08-14 1:1:0 pm NewAmsterdam Pharma Announces Appointment of William “BJ” Jones, formerly of Biohaven Pharmaceuticals, as Chief Commercial Officer GlobeNewswire
2023-08-10 3:1:49 am NewAmsterdam Pharma First Half 2023 Earnings: €0.92 loss per share (vs €1.50 profit in 1H 2022) Simply Wall St.
2023-08-07 4:15:0 am NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter 2023 Financial Highlights GlobeNewswire
2023-07-25 1:1:0 pm NewAmsterdam Pharma Completes Enrollment in Pivotal Phase 3 BROADWAY Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia and/or Established Atherosclerotic Cardiovascular Disease GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information